Health Law, Cases, Materials and Problems, Abridged (American Casebook Series)

Health Law, Cases, Materials and Problems, Abridged (American Casebook Series)
by Barry R. Furrow, Thomas L. Greaney, Sandra H. Johnson, Timothy S. Jost, Robert L. Schwartz
(3)

Buy new: $144.00
52 used & new from $38.00

(Visit the Best Sellers in Health Law list for authoritative information on this product's current rank.)

Review & Description

This abridged edition continues to use the broad organization that health law teachers and students found so helpful in the last five editions. Notes material has been trimmed substantially and some cases and sections of the primary casebook have been deleted. The authors' goal was to create a book better suited for schools that have curricular space for only one course, including medical schools and schools of public health.

Product Details

• Amazon Sales Rank: #79010 in Books
• Published on: 2008-09-10
• Original language: English
• Number of items: 1
• Dimensions: 1.50" h x 7.20" w x 9.90" l, 3.40 pounds
• Binding: Paperback
• 880 pages

EMTALA Answer Book, 2012 Edition

EMTALA Answer Book, 2012 Edition
by Mark M. Moy

Buy new: $279.00
31 used & new from $124.07

(Visit the Best Sellers in Health Law list for authoritative information on this product's current rank.)

Review & Description

The 2012 Edition of The EMTALA Answer Book shows how the Emergency Medical Treatment and Active Labor Act (EMTALA) affects not only emergency physicians but on-call physicians, specialists, and hospitals. And it shows how the feds have stepped up enforcement against EMTALA violations.

But most importantly, The EMTALA Answer Book shows you how to meet these medical duties, stave off these legal threats, and avoid fines, bad publicity, and exclusion from Medicare.

Some of the questions that The EMTALA Answer Book addresses include:

• Does HIPAA affect a hospital's EMTALA obligations?
• Must a receiving hospital with specialized capabilities accept an EMTALA patient who had been admitted as an inpatient at another hospital?
• Can a physician be on call at more than one facility simultaneously?
• Are community call plans allowed by EMTALA?
• Can a hospital compensate on-call physicians specifically for treating patients who are indigent or uninsured?
• And many more!

Product Details

• Amazon Sales Rank: #77392 in Books
• Published on: 2011-10-20
• Original language: English
• Number of items: 1
• Dimensions: .0" h x .0" w x .0" l, .0 pounds
• Binding: Paperback
• 624 pages

Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation (Institute for Policy Innovation Books)

Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation (Institute for Policy Innovation Books)
by Richard A. Epstein
(1)

Buy new: $22.00
27 used & new from $7.40

(Visit the Most Wished For in Health Law list for authoritative information on this product's current rank.)

Review & Description

This book is the first to offer a comprehensive examination of the pharmaceutical industry by following the tortuous course of a new drug as it progresses from early development to final delivery. Richard A. Epstein looks closely at the regulatory framework that surrounds all aspects of making pharmaceutical products today, and he assesses which current legal and regulatory practices make sense and which have gone awry. 
While critics of pharmaceutical companies call for ever more stringent controls on virtually every aspect of drug development and approval, Epstein cautions that the effect of such an approach will be to stifle pharmaceutical innovation and slow the delivery of beneficial treatments to the patients who need them. The author considers an array of challenges that confront the industry--conflicts of interest among government, academe, and the drug companies; intellectual property rights that govern patents; FDA regulation; pricing disputes; marketing practices; and liability issues, including those brought to light in the recent VIOXX case. Epstein argues that to ensure the continuing creativity, efficiency, and success of the pharmaceutical industry, the best system will feature strong property rights and clearly enforceable contracts, with minimal regulatory and judicial interference.

Product Details

• Amazon Sales Rank: #1071580 in Books
• Published on: 2008-12-02
• Original language: English
• Number of items: 1
• Dimensions: .70" h x 6.10" w x 9.20" l, .95 pounds
• Binding: Paperback
• 296 pages